These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 6426080)
1. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP. Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080 [TBL] [Abstract][Full Text] [Related]
2. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders. Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444 [TBL] [Abstract][Full Text] [Related]
3. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities. Moffat EH; Giddings JC; Bloom AL Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337 [TBL] [Abstract][Full Text] [Related]
4. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli. Vicente V; Alberca I; Mannucci PM Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078 [No Abstract] [Full Text] [Related]
5. Effect of propranolol, barbiturate anesthesia and splenectomy on factor VIII:C and plasminogen activator release induced by DDAVP. An experimental study on the dog. Pina-Cabral JM; Cunha-Monteiro A; Sousa-Dias MC; Andrade JA Thromb Haemost; 1989 Sep; 62(2):784-7. PubMed ID: 2510352 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects. MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807 [TBL] [Abstract][Full Text] [Related]
8. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patients. Brommer EJ; Schicht I; Wijngaards G; Verheijen JH; Rijken DC Thromb Haemost; 1984 Dec; 52(3):311-4. PubMed ID: 6085194 [TBL] [Abstract][Full Text] [Related]
10. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP. vd Knaap JH; de Boer AC; Pannebakker MA; van Heerde W; den Ottolander GJ Thromb Haemost; 1985 Feb; 53(1):118-21. PubMed ID: 3922075 [TBL] [Abstract][Full Text] [Related]
12. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Lethagen S; Harris AS; Sjörin E; Nilsson IM Thromb Haemost; 1987 Dec; 58(4):1033-6. PubMed ID: 3127915 [TBL] [Abstract][Full Text] [Related]
13. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII). Garcia VV; Silva IA; Borrasca AL Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP). Köhler M; Hellstern P; Miyashita C; von Blohn G; Wenzel E Thromb Haemost; 1986 Feb; 55(1):108-11. PubMed ID: 3085261 [TBL] [Abstract][Full Text] [Related]
15. The influence of DDAVP infusion on the coagulation and fibrinolytic response to surgery. Melissari E; Scully MF; Paes T; Ellis V; Kakkar VV Thromb Haemost; 1986 Feb; 55(1):54-7. PubMed ID: 3085264 [TBL] [Abstract][Full Text] [Related]
16. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599 [TBL] [Abstract][Full Text] [Related]
17. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects. Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902 [TBL] [Abstract][Full Text] [Related]
18. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma. Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861 [TBL] [Abstract][Full Text] [Related]
19. Effects of aspirin and propranolol on the acute psychological stress response in factor VIII coagulant activity: a randomized, double-blind, placebo-controlled experimental study. von Känel R; Kudielka BM; Helfricht S; Metzenthin P; Preckel D; Haeberli A; Cung T; Fischer JE Blood Coagul Fibrinolysis; 2008 Jan; 19(1):75-81. PubMed ID: 18180620 [TBL] [Abstract][Full Text] [Related]
20. Effect of DDAVP on plasma level of factor XII. Nenci GG; Berrettini M; De Cunto M; Agnelli G Br J Haematol; 1983 Jul; 54(3):489-92. PubMed ID: 6407513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]